Suppr超能文献

使用离散选择模型评估对钩端螺旋体病疫苗的偏好和支付意愿。

Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine.

作者信息

Arbiol Joseph, Yabe Mitsuyasu, Nomura Hisako, Borja Maridel, Gloriani Nina, Yoshida Shin-ichi

机构信息

a Laboratory of Environmental Economics; Graduate School of Bio-resources and Bio-environmental Science ; Kyushu University ; Fukuoka , Japan.

出版信息

Hum Vaccin Immunother. 2015;11(4):1046-56. doi: 10.1080/21645515.2015.1010901.

Abstract

Leptospirosis is highly endemic in the Philippines and a serious concern to public health. Local research on candidate vaccine is moving through the development pipeline. The availability of vaccines alone does not guarantee acceptance because individuals' vaccination choice decision is influenced by several factors. This study assessed how vaccine attributes and socio-demographic factors affect the acceptability of leptospirosis vaccine; and estimated individuals' willingness to pay for leptospirosis vaccine. A discrete choice experiment was conducted among leptospirosis and non-leptospirosis case respondents (n = 342) living in Metro Manila. Random Parameters Logit model was used to estimate the relative importance of vaccine attributes and socio-demographic variables on respondents' leptospirosis vaccination choice decision. The estimated model coefficients were used to derive implicit prices and willingness to pay for leptospirosis vaccine. Both case respondents preferred leptospirosis vaccine with 70-100% efficacy, mild to moderate risk of side-effects, given in a single shot, and at a lower price. Non-leptospirosis case respondents preferred a vaccine with 7 to 10 y of protection, while leptospirosis case respondents preferred a vaccine with 10 y protection. The probability of leptospirosis vaccination acceptance was affected by respondents' age, education, family size and income, proximity of home to rivers and sewers, and leptospirosis awareness level. Respondents' willingness to pay for leptospirosis vaccine (US$ 31.14-US$ 65.89) was higher than the Japanese retail price (US$ 21.60-US$ 24.00). Our findings indicated significant potential for introducing leptospirosis vaccine in the Philippine vaccine market. Delivery strategies to ensure equitable access to future leptospirosis vaccine are recommended.

摘要

钩端螺旋体病在菲律宾高度流行,是公共卫生领域的一个严重问题。当地关于候选疫苗的研究正在按开发流程推进。仅疫苗的可获得性并不能保证其被接受,因为个人的疫苗接种选择决定受到多种因素的影响。本研究评估了疫苗属性和社会人口因素如何影响钩端螺旋体病疫苗的可接受性;并估计了个人为钩端螺旋体病疫苗支付的意愿。在居住在马尼拉大都会的钩端螺旋体病病例和非钩端螺旋体病病例受访者(n = 342)中进行了一项离散选择实验。使用随机参数逻辑模型来估计疫苗属性和社会人口变量对受访者钩端螺旋体病疫苗接种选择决定的相对重要性。估计的模型系数用于得出钩端螺旋体病疫苗的隐含价格和支付意愿。两类病例受访者都更喜欢效力为70 - 100%、副作用风险为轻度至中度、单次注射且价格较低的钩端螺旋体病疫苗。非钩端螺旋体病病例受访者更喜欢具有7至10年保护期的疫苗,而钩端螺旋体病病例受访者更喜欢具有10年保护期的疫苗。钩端螺旋体病疫苗接种接受的概率受到受访者的年龄、教育程度、家庭规模和收入、家与河流和下水道的距离以及钩端螺旋体病认知水平的影响。受访者为钩端螺旋体病疫苗支付的意愿(31.14美元至65.89美元)高于日本零售价(21.60美元至24.00美元)。我们的研究结果表明在菲律宾疫苗市场引入钩端螺旋体病疫苗具有巨大潜力。建议采取确保公平获取未来钩端螺旋体病疫苗的交付策略。

相似文献

1
Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine.
Hum Vaccin Immunother. 2015;11(4):1046-56. doi: 10.1080/21645515.2015.1010901.
2
Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Vaccine. 2016 Jan 27;34(5):671-677. doi: 10.1016/j.vaccine.2015.11.075. Epub 2015 Dec 28.
6
Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment.
Pharmacoecon Open. 2022 Sep;6(5):669-679. doi: 10.1007/s41669-022-00359-x. Epub 2022 Aug 23.
7
German travelers' preferences for travel vaccines assessed by a discrete choice experiment.
Vaccine. 2018 Feb 8;36(7):969-978. doi: 10.1016/j.vaccine.2018.01.004. Epub 2018 Jan 12.
8
Individual preferences for COVID-19 vaccination in China.
Vaccine. 2021 Jan 8;39(2):247-254. doi: 10.1016/j.vaccine.2020.12.009. Epub 2020 Dec 5.
9
Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference.
Health Expect. 2022 Jun;25(3):959-970. doi: 10.1111/hex.13439. Epub 2022 Jan 20.
10
Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives.
Soc Sci Med. 2018 Jun;207:106-116. doi: 10.1016/j.socscimed.2018.04.038. Epub 2018 May 1.

引用本文的文献

1
Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2333098. doi: 10.1080/21645515.2024.2333098. Epub 2024 Apr 15.
3
Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment.
Lancet Reg Health West Pac. 2022 Oct;27:100534. doi: 10.1016/j.lanwpc.2022.100534. Epub 2022 Aug 9.
4
Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review.
Pharmacoeconomics. 2022 Oct;40(10):943-956. doi: 10.1007/s40273-022-01178-y. Epub 2022 Aug 12.
6
The demand for a COVID-19 vaccine in Kenya.
Hum Vaccin Immunother. 2021 Oct 3;17(10):3463-3471. doi: 10.1080/21645515.2021.1938494. Epub 2021 Jul 9.
7
Preference of influenza vaccination among the elderly population in Shaanxi province, China.
Hum Vaccin Immunother. 2021 Sep 2;17(9):3119-3125. doi: 10.1080/21645515.2021.1913029. Epub 2021 May 5.
8
Parental Vaccine Preferences for Their Children in China: A Discrete Choice Experiment.
Vaccines (Basel). 2020 Nov 16;8(4):687. doi: 10.3390/vaccines8040687.
9
The demand for a COVID-19 vaccine in Ecuador.
Vaccine. 2020 Dec 3;38(51):8090-8098. doi: 10.1016/j.vaccine.2020.11.013. Epub 2020 Nov 6.
10
Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia.
Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080. doi: 10.1080/21645515.2020.1819741. Epub 2020 Sep 29.

本文引用的文献

5
Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia.
PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2427. doi: 10.1371/journal.pntd.0002427. eCollection 2013.
7
The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine.
Vaccine. 2013 Aug 12;31(36):3712-7. doi: 10.1016/j.vaccine.2013.05.089. Epub 2013 Jun 5.
8
Valuing human leptospirosis prevention using the opportunity cost of labor.
Int J Environ Res Public Health. 2013 May 3;10(5):1845-60. doi: 10.3390/ijerph10051845.
9
Whole-cell inactivated leptospirosis vaccine: future prospects.
Hum Vaccin Immunother. 2013 Apr;9(4):763-5. doi: 10.4161/hv.23059. Epub 2013 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验